Restoration of normal experimental DNCB hypersensitivity development in symptom-free patients with psoriasis.
D004137:Dinitrochlorobenzene / Q000276:immunology*; D004342:Drug Hypersensitivity / Q000150:complications* / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D009578:Nitrobenzenes / Q000276:immunology*; D011565:Psoriasis / Q000276:immunology*; D012397:Rosette Formation
D004137:Dinitrochlorobenzene; D009578:Nitrobenzenes